LUNG DISEASE, INTERSTITIAL

Clinical trials for LUNG DISEASE, INTERSTITIAL explained in plain language.

Never miss a new study

Get alerted when new LUNG DISEASE, INTERSTITIAL trials appear

Sign up with your email to follow new studies for LUNG DISEASE, INTERSTITIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for stubborn lung disease when first treatments fail

Disease control Completed

This study tested whether adding the drug rituximab to standard mycophenolate treatment helps adults with progressive interstitial lung disease (ILD) who didn't improve on their first immunosuppressive therapy. The goal was to see if this combination could better preserve lung fu…

Matched conditions: LUNG DISEASE, INTERSTITIAL

Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

LUNG DISEASE, INTERSTITIAL

Get alerted when new LUNG DISEASE, INTERSTITIAL trials appear

New hope for stubborn lung disease when first treatments fail